Aballi John

President and CEO, DirectorEXAGEN INC. (XGN) · full profile →Form 4 · filed Mar 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$57K
Net Open-Market Flow
-$57K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2026Grant(A)3K$3.08$8K690K
Mar 3, 2026Sell(S)16K$3.62$57K687K

Transaction Codes

A
Grant / award
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001843113-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly: